# EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 Balance Sheet

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001099800-26-000043
- Page: https://plicit.ai/financials/ew/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/ew-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 13,867,100,000 US dollars
- **Current assets**: 6,818,900,000 US dollars
- **Non-current assets**: 7,048,200,000 US dollars
- **Liabilities**: 3,142,200,000 US dollars
- **Current liabilities**: 1,507,900,000 US dollars
- **Non-current liabilities**: 1,634,300,000 US dollars
- **Equity**: 10,724,900,000 US dollars
- **Noncontrolling interest**: 106,900,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 2,906,500,000 US dollars
- **Short-term investments (Note 5)**: 1,346,200,000 US dollars
- **Inventories (Note 2)**: 1,131,200,000 US dollars
- **Accounts receivable, net of allowances of $16.0 and $15.0, respectively**: 770,400,000 US dollars
- **Other current assets**: 360,300,000 US dollars
- **Other receivables**: 185,300,000 US dollars
- **Prepaid expenses**: 119,000,000 US dollars
- **Goodwill**: 1,951,200,000 US dollars
- **Property, plant, and equipment, net**: 1,841,800,000 US dollars
- **Other intangible assets, net**: 1,382,600,000 US dollars
- **Deferred income taxes**: 911,800,000 US dollars
- **Other assets (Note 2)**: 616,400,000 US dollars
- **Long-term investments (Note 5)**: 244,100,000 US dollars
- **Operating lease right-of-use assets**: 100,300,000 US dollars
- **Accrued and other liabilities (Note 2)**: 1,273,300,000 US dollars
- **Accounts payable**: 210,500,000 US dollars
- **Operating lease liabilities**: 24,100,000 US dollars
- **Long-term debt**: 598,700,000 US dollars
- **Uncertain tax positions**: 572,200,000 US dollars
- **Other liabilities**: 381,800,000 US dollars
- **Operating lease liabilities**: 81,600,000 US dollars
- **Retained earnings**: 14,863,100,000 US dollars
- **Additional paid-in capital**: 2,975,900,000 US dollars
- **Common stock, $1.00 par value, 1,050.0 shares authorized, 661.7 and 658.7 shares issued, and 576.6 and 580.7 shares outstanding, respectively**: 661,700,000 US dollars
- **Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding**: 0 US dollars
- **Noncontrolling interest**: 106,900,000 US dollars
- **Treasury stock, at cost, 85.1 and 78.0 shares, respectively**: negative 7,668,100,000 US dollars
- **Accumulated other comprehensive loss (Note 13)**: negative 214,600,000 US dollars
- **Gross equity (calculated)**: 18,607,600,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.